Five-Decade Update on Chemopreventive and Other Pharmacological Potential of Kurarinone: a Natural Flavanone
暂无分享,去创建一个
[1] Shih-Chao Lin,et al. Kurarinone Attenuates Collagen-Induced Arthritis in Mice by Inhibiting Th1/Th17 Cell Responses and Oxidative Stress , 2021, International journal of molecular sciences.
[2] A. Singh,et al. Characterization of phytochemicals and validation of antioxidant and anticancer activity in some Indian polyherbal ayurvedic products , 2021, Vegetos.
[3] Sixian Liang,et al. Molecular Evidence of Compound Kushen Injection against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine. , 2021, Anti-Cancer Agents in Medicinal Chemistry.
[4] Navaneet Chaturvedi,et al. Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs , 2021, Molecules.
[5] A. Singh,et al. Induction of apoptosis in breast cancer cells by naphthylisoquinoline alkaloids. , 2020, Toxicology and applied pharmacology.
[6] Jian Wang,et al. An In Vitro Study for Evaluating Permeability and Metabolism of Kurarinone , 2020, Evidence-based complementary and alternative medicine : eCAM.
[7] Y. Inoue,et al. Anti-Inflammatory Activity of Kurarinone Involves Induction of HO-1 via the KEAP1/Nrf2 Pathway , 2020, Antioxidants.
[8] A. Singh,et al. 3-O-(E)-p-Coumaroyl betulinic acid possess anticancer activity and inhibit Notch signaling pathway in breast cancer cells and mammosphere. , 2020, Chemico-biological interactions.
[9] Xiaosong Huang,et al. Pharmacokinetic and bioavailability study of kurarinone in dog plasma by UHPLC-MS/MS. , 2020, Biomedical chromatography : BMC.
[10] J. Min,et al. Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells , 2020, Journal of clinical medicine.
[11] Shumei Wang,et al. Integrated metabolomics and network pharmacology strategy for ascertaining the quality marker of flavonoids for Sophora flavescens. , 2020, Journal of pharmaceutical and biomedical analysis.
[12] Seshu Vardhan Pothabathula,et al. Prenylated flavonoids as a promising drug discovery candidate , 2020 .
[13] A. Singh,et al. Bulbine frutescens phytochemical inhibits notch signaling pathway and induces apoptosis in triple negative and luminal breast cancer cells. , 2019, Life sciences.
[14] Y. Inoue,et al. Kurarinone from Sophora Flavescens Roots Triggers ATF4 Activation and Cytostatic Effects Through PERK Phosphorylation , 2019, Molecules.
[15] Shih-Chao Lin,et al. Antitumor effect of kurarinone and underlying mechanism in small cell lung carcinoma cells , 2019, OncoTargets and therapy.
[16] L. Chu,et al. Flavonoids as human carboxylesterase 2 inhibitors: Inhibition potentials and molecular docking simulations. , 2019, International journal of biological macromolecules.
[17] M. Yohda,et al. Anti-inflammatory activity of Tetragronula species from Indonesia , 2018, Saudi journal of biological sciences.
[18] Weiyan Chen,et al. Simultaneous Optimization for Ultrasound-Assisted Extraction and Antioxidant Activity of Flavonoids from Sophora flavescens Using Response Surface Methodology , 2018, Molecules.
[19] Chul-Seung Park,et al. Direct Activation of the Large-Conductance Calcium-Activated Potassium Channel by Flavonoids Isolated from Sophora flavescens. , 2018, Biological and Pharmaceutical Bulletin.
[20] Wei Wu,et al. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation , 2018, International immunopharmacology.
[21] Defeng Li,et al. Identifying potential quality markers of Xin-Su-Ning capsules acting on arrhythmia by integrating UHPLC-LTQ-Orbitrap, ADME prediction and network target analysis. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[22] Mi Huang,et al. Inhibitory Effect of Kurarinone on Growth of Human Non-small Cell Lung Cancer: An Experimental Study Both in Vitro and in Vivo Studies , 2018, Front. Pharmacol..
[23] S. Kumar. Secondary metabolite and functional food components: Role in health and disease , 2018 .
[24] Yutong Huang,et al. Hepatotoxicity Induced by Sophora flavescens and Hepatic Accumulation of Kurarinone, a Major Hepatotoxic Constituent of Sophora flavescens in Rats , 2017, Molecules.
[25] J. Duan,et al. [Analysis and evaluation of alkaloids and flavonoids in flower of Sophora flavescens from Shanxi province]. , 2016, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[26] Xia Li,et al. Determination of sophoraflavanone G and kurarinone in rat plasma by UHPLC-MS/MS and its application to a pharmacokinetic study. , 2016, Journal of separation science.
[27] J. Cheong,et al. Urinary Bladder-Relaxant Effect of Kurarinone Depending on Potentiation of Large-Conductance Ca2+-Activated K+ Channels , 2016, Molecular Pharmacology.
[28] Weike Su,et al. Selective Extraction of Flavonoids from Sophora flavescens Ait. by Mechanochemistry , 2016, Molecules.
[29] P. Jiang,et al. Metabolism of kurarinone by human liver microsomes and its effect on cytotoxicity , 2016, Pharmaceutical biology.
[30] Hong-bo Wang,et al. Determination of kurarinone in rat plasma by UPLC-MS/MS. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[31] Wenchao Zhou,et al. Kurarinone Synergizes TRAIL-Induced Apoptosis in Gastric Cancer Cells , 2014, Cell Biochemistry and Biophysics.
[32] A. Pandey,et al. In Vitro Antioxidant, Antibacterial, and Cytotoxic Activity and In Vivo Effect of Syngonium podophyllum and Eichhornia crassipes Leaf Extracts on Isoniazid Induced Oxidative Stress and Hepatic Markers , 2014, BioMed research international.
[33] Wei Li,et al. Protein Tyrosine Phosphatase 1B Inhibitory Activity of Lavandulyl Flavonoids from Roots of Sophora flavescens , 2014, Planta Medica.
[34] A. Pandey,et al. Chemistry and Biological Activities of Flavonoids: An Overview , 2013, TheScientificWorldJournal.
[35] Xiaojun Ni,et al. Identifying 2 prenylflavanones as potential hepatotoxic compounds in the ethanol extract of Sophora flavescens. , 2013, Journal of food science.
[36] Dao-feng Chen,et al. Qualitative and quantitative analysis of flavonoids in Sophora tonkinensis by LC/MS and HPLC. , 2013, Chinese journal of natural medicines.
[37] Y. Okada,et al. Identification of a Xanthine Oxidase-inhibitory Component from Sophora Flavescens using NMR-based Metabolomics , 2013, Natural product communications.
[38] Zhi-min Wang,et al. [Non-alkaloid components from Sophora flavescens]. , 2013, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[39] A. Saxena,et al. Bauhinia variegata Leaf Extracts Exhibit Considerable Antibacterial, Antioxidant, and Anticancer Activities , 2013, BioMed research international.
[40] F. Chu,et al. [HPLC fingerprint of flavonoids in Sophora flavescens and determination of five components]. , 2013, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[41] Jongheon Shin,et al. Kurarinone regulates immune responses through regulation of the JAK/STAT and TCR-mediated signaling pathways. , 2013, Biochemical pharmacology.
[42] G. Bae,et al. Antimicrobial durability of air filters coated with airborne Sophora flavescens nanoparticles. , 2013, The Science of the total environment.
[43] Qipeng Yuan,et al. Microbial biotransformation of kurarinone by Cunninghamella echinulata AS 3.3400 , 2012, Journal of Asian natural products research.
[44] Qipeng Yuan,et al. Microbial transformation of Norkurarinone by Cunninghamella blakesleana AS 3.970 , 2012, Journal of Asian natural products research.
[45] M. Won,et al. Kurarinone promotes TRAIL-induced apoptosis by inhibiting NF-κB-dependent cFLIP expression in HeLa cells , 2012, Experimental & Molecular Medicine.
[46] W. V. Berghe,et al. Attenuation of ERK/RSK2-driven NFκB gene expression and cancer cell proliferation by kurarinone, a lavandulyl flavanone isolated from Sophora flavescens ait. roots. , 2011, Endocrine, metabolic & immune disorders drug targets.
[47] Xinluan Wang,et al. Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei--an in vitro efficacy study. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[48] I. Baburin,et al. HPLC-based activity profiling for GABAA receptor modulators from the traditional Chinese herbal drug Kushen (Sophora flavescens root) , 2011, Molecular Diversity.
[49] K. Park,et al. Lavandulyl flavonoids from Sophora flavescens suppress lipopolysaccharide-induced activation of nuclear factor-kappaB and mitogen-activated protein kinases in RAW264.7 cells. , 2010, Biological & pharmaceutical bulletin.
[50] S. J. Park,et al. Neuroprotective effects of an alkaloid-free ethyl acetate extract from the root of Sophora flavescens Ait. against focal cerebral ischemia in rats. , 2009, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[51] G. Jeong,et al. Lavandulyl flavanones from Sophora flavescens protect mouse hippocampal cells against glutamate-induced neurotoxicity via the induction of heme oxygenase-1. , 2008, Biological & pharmaceutical bulletin.
[52] Y H Moon,et al. Kurarinol, tyrosinase inhibitor isolated from the root of Sophora flavescens. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[53] Hong Liang,et al. [Main flavonoids from Sophora flavescenes]. , 2008, Yao xue xue bao = Acta pharmaceutica Sinica.
[54] H. Chung,et al. Re-evaluation of the antioxidant prenylated flavonoids from the roots of Sophora flavescens. , 2008, Biological & pharmaceutical bulletin.
[55] Mingyu Sun,et al. [Antitumor activities of kushen flavonoids in vivo and in vitro]. , 2008, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.
[56] Q. Liao,et al. Characterization of flavonoids in the extract of Sophora flavescens Ait. by high-performance liquid chromatography coupled with diode-array detector and electrospray ionization mass spectrometry. , 2007, Journal of pharmaceutical and biomedical analysis.
[57] H. Kawahara,et al. Na+-glucose cotransporter (SGLT) inhibitory flavonoids from the roots of Sophora flavescens. , 2007, Bioorganic & medicinal chemistry.
[58] S. Xiong,et al. Kushen flavonoids induce apoptosis in tumor cells by inhibition of NF‐κB activation and multiple receptor tyrosine kinase activities , 2007, Phytotherapy research : PTR.
[59] Jeong-Hill Park,et al. Identification and characterization of antioxidants from Sophora flavescens. , 2006, Biological & pharmaceutical bulletin.
[60] K. Park,et al. Glycosidase inhibitory flavonoids from Sophora flavescens. , 2006, Biological & pharmaceutical bulletin.
[61] Q. Yu,et al. [Clinical study on treatment of chronic hepatitis B by kurarinone combined with interferon alpha-1b]. , 2005, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
[62] D. Heber,et al. Inhibition of Growth of Streptococcus mutans, Methicillin-Resistant Staphylococcus aureus, and Vancomycin-Resistant Enterococci by Kurarinone, a Bioactive Flavonoid Isolated from Sophora flavescens , 2005, Journal of Clinical Microbiology.
[63] Young Kook Kim,et al. Kurarinone isolated from Sophora flavescens Ait inhibited MCP-1-induced chemotaxis. , 2005, Journal of ethnopharmacology.
[64] H. Sohn,et al. Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. , 2004, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[65] G. Haegeman,et al. Estrogenic and anticarcinogenic properties of kurarinone, a lavandulyl flavanone from the roots of Sophora flavescens. , 2004, Journal of natural products.
[66] J. Choi,et al. Isolation of flavonoids and a cerebroside from the stem bark ofAlbizzia julibrissin , 2004, Archives of pharmacal research.
[67] Young Kook Kim,et al. In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens. , 2004, Planta medica.
[68] Hyun Pyo Kim,et al. Tyrosinase inhibitory prenylated flavonoids from Sophora flavescens. , 2003, Biological & pharmaceutical bulletin.
[69] Jeong Ah Kim,et al. Prenylated flavonoids from the roots of Sophora flavescens with tyrosinase inhibitory activity. , 2003, Planta medica.
[70] Hyun Pyo Kim,et al. Effects of sophoraflavanone g, a prenylated flavonoid from sophoraFlavescens, on cyclooxygenase-2 andIn Vivo inflammatory response , 2002, Archives of pharmacal research.
[71] H. W. Chang,et al. Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachidonic acid: cyclooxygenases and lipoxygenases. , 2001, Biochemical pharmacology.
[72] T. Miyamoto,et al. Cytotoxic lavandulyl flavanones from Sophora flavescens. , 2000, Journal of natural products.
[73] S. Ryu,et al. P-glycoprotein (Pgp) does not affect the cytotoxicity of flavonoids from Sophora flavescens, which also have no effects on Pgp action. , 1999, Anticancer research.
[74] W. Ma,et al. Acyl secoiridoids and antifungal constituents from Gentiana macrophylla. , 1996, Phytochemistry.
[75] J. Yamahara,et al. Vasodilatory active principles of Sophora flavescens root. , 1990, Journal of ethnopharmacology.
[76] T. Tomimori,et al. [Studies on the constituents of Sophora species. IV. Constituents of the root of Sophora angustifolia Sieb. et Zucc]. , 1970, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.